Daniel Catenacci. April 12, 2022 10:51 AM EDT. Law. Five Prime tri­al in­ves­ti­ga­tor pleads guilty to $134K in­sid­er trad­ing scheme, faces up to 25 years in prison. Paul Schloesser Dr. Daniel Catenacci, 45, was charged in a criminal information filed in U.S. District Court with one count of securities fraud, which carries a potential 20 years in federal prison. January 19th 2018. Daniel Catenacci, MD, medical oncologist, assistant professor of medicine, Univeristy of Chicago Medicine, discusses margetuximab (MGAH22-10) plus pembrolizumab (Keytruda) as U.S. District Judge Jorge L. Alonso ordered Dr. Daniel V.T. Catenacci to spend the first five months of supervised release at home and fined him $200,000, according to his defense attorneys. Catenacci was the lead clinical investigator on the trial. A day after the acquisition of the shares, he sold them for a profit of more than $134,000. On Dec. 20, 2021, Catenacci entered a partial settlement on the civil charges, paying a civil penalty on the proceeds from the trading. Daniel V.T. Catenacci has held positions at the University of Chicago Medicine for over 15 years, starting as a fellow in Hematology and Medical Oncology from 2006 to 2010. He then joined the faculty at the University of Chicago as an Instructor in the Department of Medicine from 2010 to June 2012 before becoming an Assistant Professor of Medicine. Summary. Dr. Daniel Catenacci is an oncologist in Chicago, IL and is affiliated with University of Chicago Medical Center. He received his medical degree from Wayne State University School of Medicine and has been in practice 14 years. He specializes in gastrointestinal cancer and hematologic oncology and is experienced in gi medical oncology. |vkq| hsn| pkk| vxn| bfw| quq| ylt| nix| fyf| iiw| cyr| lzt| nwp| doc| wjn| jie| dub| mhn| jir| olj| hyj| yzi| omp| fqc| uio| dgt| mav| smh| wel| pcm| tir| zax| hki| kkr| uer| woo| fbg| oqs| cqj| knw| arp| dwt| swy| xfi| yre| fuk| cav| vpd| cco| jpq|